{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T18:18:50Z","timestamp":1790014730092,"version":"4.0.1"},"reference-count":223,"publisher":"Oxford University Press (OUP)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,5]]},"DOI":"10.1093\/brain\/awu002","type":"journal-article","created":{"date-parts":[[2014,2,16]],"date-time":"2014-02-16T01:14:53Z","timestamp":1392513293000},"page":"1304-1322","source":"Crossref","is-referenced-by-count":136,"title":["Glucocerebrosidase is shaking up the synucleinopathies"],"prefix":"10.1093","volume":"137","author":[{"given":"Marina","family":"Siebert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen","family":"Sidransky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy","family":"Westbroek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2014,2,14]]},"reference":[{"key":"key\n\t\t\t\t20170405101858_awu002-B1","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0896-6273(00)80886-7","article-title":"Mice lacking alpha-synuclein display functional deficits in the nigrostriatal dopamine system","volume":"25","author":"Abeliovich","year":"2000","journal-title":"Neuron"},{"key":"key\n\t\t\t\t20170405101858_awu002-B2","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/j.jmb.2006.08.009","article-title":"Direct visualization of saposin remodelling of lipid bilayers","volume":"362","author":"Alattia","year":"2006","journal-title":"J Mol Biol"},{"key":"key\n\t\t\t\t20170405101858_awu002-B3","doi-asserted-by":"crossref","first-page":"17394","DOI":"10.1073\/pnas.0704998104","article-title":"Molecular imaging of membrane interfaces reveals mode of beta-glucosidase activation by saposin C","volume":"104","author":"Alattia","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"key\n\t\t\t\t20170405101858_awu002-B4","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1001\/archneurol.2010.198","article-title":"Chaperone-mediated autophagy markers in Parkinson disease brains","volume":"67","author":"Alvarez-Erviti","year":"2010","journal-title":"Arch Neurol"},{"key":"key\n\t\t\t\t20170405101858_awu002-B5","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.nbd.2011.01.029","article-title":"Lysosomal dysfunction increases exosome-mediated alpha-synuclein release and transmission","volume":"42","author":"Alvarez-Erviti","year":"2011","journal-title":"Neurobiol Dis"},{"key":"key\n\t\t\t\t20170405101858_awu002-B7","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1212\/WNL.0b013e318245f476","article-title":"Penetrance of Parkinson disease in glucocerebrosidase gene mutation carriers","volume":"78","author":"Anheim","year":"2012","journal-title":"Neurology"},{"key":"key\n\t\t\t\t20170405101858_awu002-B8","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.ceb.2010.10.009","article-title":"Chaperone-mediated autophagy in protein quality control","volume":"23","author":"Arias","year":"2011","journal-title":"Curr Opin Cell Biol"},{"key":"key\n\t\t\t\t20170405101858_awu002-B9","doi-asserted-by":"crossref","first-page":"683920","DOI":"10.1155\/2013\/683920","article-title":"Neuroprotective function of DJ-1 in Parkinson's disease","volume":"2013","author":"Ariga","year":"2013","journal-title":"Oxid Med Cell Longev"},{"key":"key\n\t\t\t\t20170405101858_awu002-B10","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1615\/CritRevOncog.2013006061","article-title":"Gaucher disease and myeloma","volume":"18","author":"Ayto","year":"2013","journal-title":"Crit Rev Oncog"},{"key":"key\n\t\t\t\t20170405101858_awu002-B11","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.ymgme.2012.04.018","article-title":"Pharmacological chaperones facilitate the post-ER transport of recombinant N370S mutant beta-glucocerebrosidase in plant cells: evidence that N370S is a folding mutant","volume":"106","author":"Babajani","year":"2012","journal-title":"Mol Genet Metab"},{"key":"key\n\t\t\t\t20170405101858_awu002-B12","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1002\/mds.21399","article-title":"Lysosomal hydrolases in cerebrospinal fluid from subjects with Parkinson's disease","volume":"22","author":"Balducci","year":"2007","journal-title":"Mov Disord"},{"key":"key\n\t\t\t\t20170405101858_awu002-B13","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.1093\/hmg\/ddn124","article-title":"A nonsense mutation in the LIMP-2 gene associated with progressive myoclonic epilepsy and nephrotic syndrome","volume":"17","author":"Balreira","year":"2008","journal-title":"Hum Mol Genet"},{"key":"key\n\t\t\t\t20170405101858_awu002-B14","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1056\/NEJM199105233242104","article-title":"Replacement therapy for inherited enzyme deficiency\u2013macrophage-targeted glucocerebrosidase for Gaucher's disease","volume":"324","author":"Barton","year":"1991","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20170405101858_awu002-B15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00439-006-0280-4","article-title":"New therapeutic options for lysosomal storage disorders: enzyme replacement, small molecules and gene therapy","volume":"121","author":"Beck","year":"2007","journal-title":"Hum Genet"},{"key":"key\n\t\t\t\t20170405101858_awu002-B16","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.parkreldis.2012.06.023","article-title":"Parkinson's disease in patients and obligate carriers of Gaucher disease","volume":"19","author":"Becker","year":"2013","journal-title":"Parkinsonism Relat Disord"},{"key":"key\n\t\t\t\t20170405101858_awu002-B17","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1111\/j.1471-4159.2010.07143.x","article-title":"Induction of the unfolded protein response by alpha-synuclein in experimental models of Parkinson's disease","volume":"116","author":"Bellucci","year":"2011","journal-title":"J Neurochem"},{"key":"key\n\t\t\t\t20170405101858_awu002-B18","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1212\/01.WNL.0000072482.70963.D7","article-title":"Gaucher's disease with Parkinson's disease: clinical and pathological aspects","volume":"61","author":"Bembi","year":"2003","journal-title":"Neurology"},{"key":"key\n\t\t\t\t20170405101858_awu002-B19","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1002\/humu.22124","article-title":"Gaucher disease paradigm: from ERAD to comorbidity","volume":"33","author":"Bendikov-Bar","year":"2012","journal-title":"Hum Mutat"},{"key":"key\n\t\t\t\t20170405101858_awu002-B20","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.bcmd.2012.10.007","article-title":"Ambroxol as a pharmacological chaperone for mutant glucocerebrosidase","volume":"50","author":"Bendikov-Bar","year":"2013","journal-title":"Blood Cells Mol Dis"},{"key":"key\n\t\t\t\t20170405101858_awu002-B21","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.bcmd.2010.10.012","article-title":"Characterization of the ERAD process of the L444P mutant glucocerebrosidase variant","volume":"46","author":"Bendikov-Bar","year":"2011","journal-title":"Blood Cells Mol Dis"},{"key":"key\n\t\t\t\t20170405101858_awu002-B22","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.ajhg.2007.12.019","article-title":"Array-based gene discovery with three unrelated subjects shows SCARB2\/LIMP-2 deficiency causes myoclonus epilepsy and glomerulosclerosis","volume":"82","author":"Berkovic","year":"2008","journal-title":"Am J Hum Genet"},{"key":"key\n\t\t\t\t20170405101858_awu002-B23","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.ajhg.2007.12.019","article-title":"Array-based gene discovery with three unrelated subjects shows SCARB2\/LIMP-2 deficiency causes myoclonus epilepsy and glomerulosclerosis","volume":"82","author":"Berkovic","year":"2008","journal-title":"Am J Hum Genet"},{"key":"key\n\t\t\t\t20170405101858_awu002-B24","first-page":"3635","article-title":"Gaucher disease","volume-title":"The metabolic & molecular bases of inherited disease","author":"Beutler","year":"2001"},{"key":"key\n\t\t\t\t20170405101858_awu002-B25","first-page":"85","article-title":"Gaucher disease: gene frequencies in the Ashkenazi Jewish population","volume":"52","author":"Beutler","year":"1993","journal-title":"Am J Hum Genet"},{"key":"key\n\t\t\t\t20170405101858_awu002-B26","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1097\/nen.0b013e3181587d64","article-title":"Protein aggregation mechanisms in synucleinopathies: commonalities and differences","volume":"66","author":"Beyer","year":"2007","journal-title":"J Neuropathol Exp Neurol"},{"key":"key\n\t\t\t\t20170405101858_awu002-B27","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.bcmd.2010.10.007","article-title":"A monozygotic twin pair with highly discordant Gaucher phenotypes","volume":"46","author":"Biegstraaten","year":"2011","journal-title":"Blood Cells Mol Dis"},{"key":"key\n\t\t\t\t20170405101858_awu002-B28","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1093\/hmg\/ddp523","article-title":"Disease-causing mutations within the lysosomal integral membrane protein type 2 (LIMP-2) reveal the nature of binding to its ligand beta-glucocerebrosidase","volume":"19","author":"Blanz","year":"2010","journal-title":"Hum Mol Genet"},{"key":"key\n\t\t\t\t20170405101858_awu002-B29","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.ymgme.2009.10.189","article-title":"In silico and functional studies of the regulation of the glucocerebrosidase gene","volume":"99","author":"Blech-Hermoni","year":"2010","journal-title":"Mol Genet Metab"},{"key":"key\n\t\t\t\t20170405101858_awu002-B30","first-page":"989","article-title":"Replacement therapy for inherited enzyme deficiency","volume":"291","author":"Brady","year":"1974","journal-title":"Use of purified glucocerebrosidase in Gaucher's disease. N Engl J Med"},{"key":"key\n\t\t\t\t20170405101858_awu002-B32","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/j.cell.2012.11.012","article-title":"Cleaning up: ER-associated degradation to the rescue","volume":"151","author":"Brodsky","year":"2012","journal-title":"Cell"},{"key":"key\n\t\t\t\t20170405101858_awu002-B33","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1126\/science.1195227","article-title":"Alpha-synuclein promotes SNARE-complex assembly in vivo and in vitro","volume":"329","author":"Burre","year":"2010","journal-title":"Science"},{"key":"key\n\t\t\t\t20170405101858_awu002-B34","doi-asserted-by":"crossref","first-page":"8797","DOI":"10.1523\/JNEUROSCI.22-20-08797.2002","article-title":"Synaptic vesicle depletion correlates with attenuated synaptic responses to prolonged repetitive stimulation in mice lacking alpha-synuclein","volume":"22","author":"Cabin","year":"2002","journal-title":"J Neurosci"},{"key":"key\n\t\t\t\t20170405101858_awu002-B35","doi-asserted-by":"crossref","first-page":"e43310","DOI":"10.1371\/journal.pone.0043310","article-title":"Systemic delivery of a glucosylceramide synthase inhibitor reduces CNS substrates and increases lifespan in a mouse model of type 2 Gaucher disease","volume":"7","author":"Cabrera-Salazar","year":"2012","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20170405101858_awu002-B36","doi-asserted-by":"crossref","first-page":"2777","DOI":"10.1002\/bit.23282","article-title":"A review of the mammalian unfolded protein response","volume":"108","author":"Chakrabarti","year":"2011","journal-title":"Biotechnol Bioeng"},{"key":"key\n\t\t\t\t20170405101858_awu002-B37","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.neulet.2013.06.009","article-title":"Exosomes of BV-2 cells induced by alpha-synuclein: important mediator of neurodegeneration in PD","volume":"548","author":"Chang","year":"2013","journal-title":"Neurosci Lett"},{"key":"key\n\t\t\t\t20170405101858_awu002-B38","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.neulet.2012.03.035","article-title":"Association study of SCARB2 rs6812193 polymorphism with Parkinson's disease in Han Chinese","volume":"516","author":"Chen","year":"2012","journal-title":"Neurosci Lett"},{"key":"key\n\t\t\t\t20170405101858_awu002-B39","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s10545-010-9095-5","article-title":"The neurological manifestations of Gaucher disease type 1: the French Observatoire on Gaucher disease (FROG)","volume":"33","author":"Cherin","year":"2010","journal-title":"Journal of inherited metabolic disease"},{"key":"key\n\t\t\t\t20170405101858_awu002-B40","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/s10038-005-0258-4","article-title":"Sanfilippo type B syndrome: five patients with an R565P homozygous mutation in the alpha-N-acetylglucosaminidase gene from the Okinawa islands in Japan","volume":"50","author":"Chinen","year":"2005","journal-title":"J Hum Genet"},{"key":"key\n\t\t\t\t20170405101858_awu002-B41","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.ymgme.2011.06.008","article-title":"Aggregation of alpha-synuclein in brain samples from subjects with glucocerebrosidase mutations","volume":"104","author":"Choi","year":"2011","journal-title":"Mol Genet Metab"},{"key":"key\n\t\t\t\t20170405101858_awu002-B42","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.neulet.2012.02.035","article-title":"Association of mutations in the glucocerebrosidase gene with Parkinson disease in a Korean population","volume":"514","author":"Choi","year":"2012","journal-title":"Neurosci Lett"},{"key":"key\n\t\t\t\t20170405101858_awu002-B43","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1515\/bchm3.1986.367.2.879","article-title":"Immunochemical characterization of two activator proteins stimulating enzymic sphingomyelin degradation in vitro. Absence of one of them in a human Gaucher disease variant","volume":"367","author":"Christomanou","year":"1986","journal-title":"Biol Chem Hoppe Seyler"},{"key":"key\n\t\t\t\t20170405101858_awu002-B44","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1007\/BF01716064","article-title":"Activator protein deficient Gaucher's disease. A second patient with the newly identified lipid storage disorder","volume":"67","author":"Christomanou","year":"1989","journal-title":"Klin Wochenschr"},{"key":"key\n\t\t\t\t20170405101858_awu002-B45","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1126\/science.1245296","article-title":"Identification and rescue of alpha-synuclein toxicity in parkinson patient-derived neurons","volume":"342","author":"Chung","year":"2013","journal-title":"Science"},{"key":"key\n\t\t\t\t20170405101858_awu002-B46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neuint.2012.10.010","article-title":"Glucocerebrosidase inhibition causes mitochondrial dysfunction and free radical damage","volume":"62","author":"Cleeter","year":"2013","journal-title":"Neurochem Int"},{"key":"key\n\t\t\t\t20170405101858_awu002-B47","doi-asserted-by":"crossref","first-page":"3306","DOI":"10.1523\/JNEUROSCI.5367-11.2012","article-title":"Endoplasmic reticulum stress is important for the manifestations of alpha-synucleinopathy in vivo","volume":"32","author":"Colla","year":"2012","journal-title":"J Neurosci"},{"key":"key\n\t\t\t\t20170405101858_awu002-B48","doi-asserted-by":"crossref","first-page":"3301","DOI":"10.1523\/JNEUROSCI.5368-11.2012","article-title":"Accumulation of toxic alpha-synuclein oligomer within endoplasmic reticulum occurs in alpha-synucleinopathy in vivo","volume":"32","author":"Colla","year":"2012","journal-title":"J Neurosci"},{"key":"key\n\t\t\t\t20170405101858_awu002-B49","doi-asserted-by":"crossref","first-page":"a009423","DOI":"10.1101\/cshperspect.a009423","article-title":"Disruption of protein quality control in Parkinson's disease","volume":"2","author":"Cook","year":"2012","journal-title":"Cold Spring Harb Perspect Med"},{"key":"key\n\t\t\t\t20170405101858_awu002-B50","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1126\/science.1129462","article-title":"Alpha-synuclein blocks ER-Golgi traffic and Rab1 rescues neuron loss in Parkinson's models","volume":"313","author":"Cooper","year":"2006","journal-title":"Science"},{"key":"key\n\t\t\t\t20170405101858_awu002-B51","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.ymgme.2012.07.012","article-title":"A shortcut to the lysosome: the mannose-6-phosphate-independent pathway","volume":"107","author":"Coutinho","year":"2012","journal-title":"Mol Genet Metab"},{"key":"key\n\t\t\t\t20170405101858_awu002-B52","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1756-6606-2-5","article-title":"Cathepsin D expression level affects alpha-synuclein processing, aggregation, and toxicity in vivo","volume":"2","author":"Cullen","year":"2009","journal-title":"Mol Brain"},{"key":"key\n\t\t\t\t20170405101858_awu002-B53","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1002\/ana.22400","article-title":"Acid beta-glucosidase mutants linked to Gaucher disease, Parkinson disease, and Lewy body dementia alter alpha-synuclein processing","volume":"69","author":"Cullen","year":"2011","journal-title":"Ann. Neurol"},{"key":"key\n\t\t\t\t20170405101858_awu002-B54","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.bcmd.2005.08.004","article-title":"Increased incidence of cancer in adult Gaucher disease in Western Europe","volume":"36","author":"de Fost","year":"2006","journal-title":"Blood Cells Mol Dis"},{"key":"key\n\t\t\t\t20170405101858_awu002-B55","doi-asserted-by":"crossref","first-page":"E1817","DOI":"10.1073\/pnas.1305623110","article-title":"TFEB-mediated autophagy rescues midbrain dopamine neurons from alpha-synuclein toxicity","volume":"110","author":"Decressac","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"key":"key\n\t\t\t\t20170405101858_awu002-B56","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1002\/mds.25462","article-title":"Lysosomal impairment in Parkinson's disease","volume":"28","author":"Dehay","year":"2013","journal-title":"Mov Disord"},{"key":"key\n\t\t\t\t20170405101858_awu002-B57","doi-asserted-by":"crossref","first-page":"e60674","DOI":"10.1371\/journal.pone.0060674","article-title":"Loss of beta-glucocerebrosidase activity does not affect alpha-synuclein levels or lysosomal function in neuronal cells","volume":"8","author":"Dermentzaki","year":"2013","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20170405101858_awu002-B58","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1159\/000060184","article-title":"Fabry disease (alpha-galactosidase A deficiency): renal involvement and enzyme replacement therapy","volume":"136","author":"Desnick","year":"2001","journal-title":"Contrib Nephrol"},{"key":"key\n\t\t\t\t20170405101858_awu002-B59","doi-asserted-by":"crossref","first-page":"13010","DOI":"10.1073\/pnas.0903691106","article-title":"Inclusion formation and neuronal cell death through neuron-to-neuron transmission of alpha-synuclein","volume":"106","author":"Desplats","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"key\n\t\t\t\t20170405101858_awu002-B60","doi-asserted-by":"crossref","first-page":"e00592","DOI":"10.7554\/eLife.00592","article-title":"Native alpha-synuclein induces clustering of synaptic-vesicle mimics via binding to phospholipids and synaptobrevin-2\/VAMP2","volume":"2","author":"Diao","year":"2013","journal-title":"Elife"},{"key":"key\n\t\t\t\t20170405101858_awu002-B61","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s00439-005-1288-x","article-title":"A mutation within the saposin D domain in a Gaucher disease patient with normal glucocerebrosidase activity","volume":"117","author":"Diaz-Font","year":"2005","journal-title":"Hum Genet"},{"key":"key\n\t\t\t\t20170405101858_awu002-B62","doi-asserted-by":"crossref","first-page":"e1002141","DOI":"10.1371\/journal.pgen.1002141","article-title":"Web-based genome-wide association study identifies two novel loci and a substantial genetic component for Parkinson's disease","volume":"7","author":"Do","year":"2011","journal-title":"PLoS Genet"},{"key":"key\n\t\t\t\t20170405101858_awu002-B63","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.neulet.2010.08.083","article-title":"Mutational analysis of GIGYF2, ATP13A2 and GBA genes in Brazilian patients with early-onset Parkinson's disease","volume":"485","author":"Dos Santos","year":"2010","journal-title":"Neurosci Lett"},{"key":"key\n\t\t\t\t20170405101858_awu002-B64","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1111\/j.1582-4934.2011.01374.x","article-title":"Unfolded proteins and endoplasmic reticulum stress in neurodegenerative disorders","volume":"15","author":"Doyle","year":"2011","journal-title":"J Cell Mol Med"},{"key":"key\n\t\t\t\t20170405101858_awu002-B65","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1002\/mds.25248","article-title":"The glucocerobrosidase E326K variant predisposes to Parkinson's disease, but does not cause Gaucher's disease","volume":"28","author":"Duran","year":"2013","journal-title":"Mov Disord"},{"key":"key\n\t\t\t\t20170405101858_awu002-B66","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1002\/mds.20766","article-title":"Glucocerebrosidase mutations are also found in subjects with early-onset parkinsonism from Venezuela","volume":"21","author":"Eblan","year":"2006","journal-title":"Mov Disord"},{"key":"key\n\t\t\t\t20170405101858_awu002-B67","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1002\/mds.23950","article-title":"Glucocerebrosidase gene mutations are associated with Parkinson's disease in Russia","volume":"27","author":"Emelyanov","year":"2012","journal-title":"Mov Disord"},{"key":"key\n\t\t\t\t20170405101858_awu002-B68","doi-asserted-by":"crossref","first-page":"17483","DOI":"10.1073\/pnas.0708086104","article-title":"Murine models of acute neuronopathic Gaucher disease","volume":"104","author":"Enquist","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"key\n\t\t\t\t20170405101858_awu002-B69","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1023\/A:1012452715079","article-title":"Remaining problems in the management of patients with Gaucher disease","volume":"24","author":"Erikson","year":"2001","journal-title":"J Inherit Metab Dis"},{"key":"key\n\t\t\t\t20170405101858_awu002-B70","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0962-8924(03)00005-9","article-title":"At the acidic edge: emerging functions for lysosomal membrane proteins","volume":"13","author":"Eskelinen","year":"2003","journal-title":"Trends Cell Biol"},{"key":"key\n\t\t\t\t20170405101858_awu002-B71","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1093\/hmg\/ddp061","article-title":"No evidence for activation of the unfolded protein response in neuronopathic models of Gaucher disease","volume":"18","author":"Farfel-Becker","year":"2009","journal-title":"Hum Mol Genet"},{"issue":"Pt 5","key":"key\n\t\t\t\t20170405101858_awu002-B72","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1093\/brain\/114.5.2283","article-title":"Ageing and Parkinson's disease: substantia nigra regional selectivity","volume":"114","author":"Fearnley","year":"1991","journal-title":"Brain"},{"key":"key\n\t\t\t\t20170405101858_awu002-B73","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1172\/JCI14006","article-title":"CD36: a class B scavenger receptor involved in angiogenesis, atherosclerosis, inflammation, and lipid metabolism","volume":"108","author":"Febbraio","year":"2001","journal-title":"J Clin Invest"},{"key":"key\n\t\t\t\t20170405101858_awu002-B74","doi-asserted-by":"crossref","first-page":"2890","DOI":"10.1016\/j.neurobiolaging.2013.06.010","article-title":"A rare lysosomal enzyme gene SMPD1 variant (p.R591C) associates with Parkinson's disease","volume":"34","author":"Foo","year":"2013","journal-title":"Neurobiol Aging"},{"key":"key\n\t\t\t\t20170405101858_awu002-B75","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/0006-291X(91)90127-S","article-title":"Isolation and sequencing of a cDNA clone encoding 85kDa sialoglycoprotein in rat liver lysosomal membranes","volume":"178","author":"Fujita","year":"1991","journal-title":"Biochem Biophys Res Commun"},{"key":"key\n\t\t\t\t20170405101858_awu002-B76","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1212\/WNL.0b013e31828f180e","article-title":"The p.L302P mutation in the lysosomal enzyme gene SMPD1 is a risk factor for Parkinson disease","volume":"80","author":"Gan-Or","year":"2013","journal-title":"Neurology"},{"issue":"Pt 7","key":"key\n\t\t\t\t20170405101858_awu002-B77","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1093\/brain\/awq132","article-title":"SNARE protein redistribution and synaptic failure in a transgenic mouse model of Parkinson's disease","volume":"133","author":"Garcia-Reitbock","year":"2010","journal-title":"Brain"},{"key":"key\n\t\t\t\t20170405101858_awu002-B78","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/ana.23614","article-title":"Glucocerebrosidase deficiency in substantia nigra of parkinson disease brains","volume":"72","author":"Gegg","year":"2012","journal-title":"Ann Neurol"},{"key":"key\n\t\t\t\t20170405101858_awu002-B79","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1111\/j.1365-2958.2008.06502.x","article-title":"Ubiquitin-dependent and -independent mitochondrial protein quality controls: implications in ageing and neurodegenerative diseases","volume":"70","author":"Germain","year":"2008","journal-title":"Mol Microbiol"},{"key":"key\n\t\t\t\t20170405101858_awu002-B80","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1089\/biores.2012.0265","article-title":"Abnormal processing of autophagosomes in transformed B lymphocytes from SCARB2-deficient subjects","volume":"2","author":"Gleich","year":"2013","journal-title":"Biores Open Access"},{"key":"key\n\t\t\t\t20170405101858_awu002-B81","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1212\/01.wnl.0000230215.41296.18","article-title":"Glucocerebrosidase mutations are an important risk factor for Lewy body disorders","volume":"67","author":"Goker-Alpan","year":"2006","journal-title":"Neurology"},{"key":"key\n\t\t\t\t20170405101858_awu002-B82","doi-asserted-by":"crossref","first-page":"e37","DOI":"10.1136\/jmg.2004.028019","article-title":"Divergent phenotypes in Gaucher disease implicate the role of modifiers","volume":"42","author":"Goker-Alpan","year":"2005","journal-title":"J Med Genet"},{"key":"key\n\t\t\t\t20170405101858_awu002-B83","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1136\/jmg.2004.024455","article-title":"Parkinsonism among Gaucher disease carriers","volume":"41","author":"Goker-Alpan","year":"2004","journal-title":"J Med Genet"},{"key":"key\n\t\t\t\t20170405101858_awu002-B84","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1007\/s00401-010-0741-7","article-title":"Glucocerebrosidase is present in alpha-synuclein inclusions in Lewy body disorders","volume":"120","author":"Goker-Alpan","year":"2010","journal-title":"Acta Neuropathol"},{"key":"key\n\t\t\t\t20170405101858_awu002-B85","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1038\/nature02263","article-title":"Protein degradation and protection against misfolded or damaged proteins","volume":"426","author":"Goldberg","year":"2003","journal-title":"Nature"},{"key":"key\n\t\t\t\t20170405101858_awu002-B86","doi-asserted-by":"crossref","first-page":"e29861","DOI":"10.1371\/journal.pone.0029861","article-title":"High throughput screening for small molecule therapy for Gaucher disease using patient tissue as the source of mutant glucocerebrosidase","volume":"7","author":"Goldin","year":"2012","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20170405101858_awu002-B87","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1038\/mt.2012.28","article-title":"Glucose regulated protein 78 diminishes alpha-synuclein neurotoxicity in a rat model of Parkinson disease","volume":"20","author":"Gorbatyuk","year":"2012","journal-title":"Mol Ther"},{"key":"key\n\t\t\t\t20170405101858_awu002-B88","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.bcmd.2010.08.012","article-title":"Type 2 Gaucher disease: phenotypic variation and genotypic heterogeneity","volume":"46","author":"Gupta","year":"2011","journal-title":"Blood Cells Mol Dis"},{"key":"key\n\t\t\t\t20170405101858_awu002-B89","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1172\/JCI43366","article-title":"alpha-Synuclein propagates from mouse brain to grafted dopaminergic neurons and seeds aggregation in cultured human cells","volume":"121","author":"Hansen","year":"2011","journal-title":"J Clin Invest"},{"key":"key\n\t\t\t\t20170405101858_awu002-B90","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1006\/abbi.1997.9958","article-title":"Lysosomal proteolysis of prosaposin, the precursor of saposins (sphingolipid activator proteins): its mechanism and inhibition by ganglioside","volume":"341","author":"Hiraiwa","year":"1997","journal-title":"Arch Biochem Biophys"},{"key":"key\n\t\t\t\t20170405101858_awu002-B91","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1159\/000334536","article-title":"Activation of the unfolded protein response is an early event in Alzheimer's and Parkinson's disease","volume":"10","author":"Hoozemans","year":"2012","journal-title":"Neurodegener Dis"},{"key":"key\n\t\t\t\t20170405101858_awu002-B92","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1002\/mds.25349","article-title":"The role of SCARB2 as susceptibility factor in Parkinson's disease","volume":"28","author":"Hopfner","year":"2013","journal-title":"Mov Disord"},{"key":"key\n\t\t\t\t20170405101858_awu002-B93","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.ymgme.2011.07.002","article-title":"The enigma of the E326K mutation in acid beta-glucocerebrosidase","volume":"104","author":"Horowitz","year":"2011","journal-title":"Mol Genet Metab"},{"key":"key\n\t\t\t\t20170405101858_awu002-B94","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0888-7543(89)90319-4","article-title":"The human glucocerebrosidase gene and pseudogene: structure and evolution","volume":"4","author":"Horowitz","year":"1989","journal-title":"Genomics"},{"key":"key\n\t\t\t\t20170405101858_awu002-B95","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1002\/humu.20676","article-title":"Gaucher disease: mutation and polymorphism spectrum in the glucocerebrosidase gene (GBA)","volume":"29","author":"Hruska","year":"2008","journal-title":"Hum Mutat"},{"key":"key\n\t\t\t\t20170405101858_awu002-B96","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1111\/j.1468-1331.2011.03362.x","article-title":"Contribution of glucocerebrosidase mutation in a large cohort of sporadic Parkinson's disease in Taiwan","volume":"18","author":"Huang","year":"2011","journal-title":"Eur J Neurol"},{"key":"key\n\t\t\t\t20170405101858_awu002-B97","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1093\/hmg\/10.9.927","article-title":"A novel mutation in the coding region of the prosaposin gene leads to a complete deficiency of prosaposin and saposins, and is associated with a complex sphingolipidosis dominated by lactosylceramide accumulation","volume":"10","author":"Hulkova","year":"2001","journal-title":"Hum Mol Genet"},{"key":"key\n\t\t\t\t20170405101858_awu002-B98","doi-asserted-by":"crossref","first-page":"e1002142","DOI":"10.1371\/journal.pgen.1002142","article-title":"A two-stage meta-analysis identifies several new loci for Parkinson's disease","volume":"7","author":"International Parkinson's Disease Genomics Consortium","year":"2011","journal-title":"PLoS Genet"},{"key":"key\n\t\t\t\t20170405101858_awu002-B99","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.bbrc.2012.10.057","article-title":"alpha-Synuclein accumulation reduces GABAergic inhibitory transmission in a model of multiple system atrophy","volume":"428","author":"Ito","year":"2012","journal-title":"Biochem Biophys Res Commun"},{"key":"key\n\t\t\t\t20170405101858_awu002-B100","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/s00415-009-5363-4","article-title":"Glucocerebrosidase mutations p.L444P and p.N370S are not associated with multisystem atrophy, progressive supranuclear palsy and corticobasal degeneration in Polish patients","volume":"257","author":"Jamrozik","year":"2010","journal-title":"J Neurol"},{"key":"key\n\t\t\t\t20170405101858_awu002-B101","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1083\/jcb.201008084","article-title":"Mitochondrial membrane potential regulates PINK1 import and proteolytic destabilization by PARL","volume":"191","author":"Jin","year":"2010","journal-title":"J Cell Biol"},{"key":"key\n\t\t\t\t20170405101858_awu002-B102","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1172\/JCI0216886","article-title":"Orchestrating the unfolded protein response in health and disease","volume":"110","author":"Kaufman","year":"2002","journal-title":"J Clin Invest"},{"key":"key\n\t\t\t\t20170405101858_awu002-B103","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1111\/j.1742-4658.2010.07588.x","article-title":"The pharmacological chaperone isofagomine increases the activity of the Gaucher disease L444P mutant form of beta-glucosidase","volume":"277","author":"Khanna","year":"2010","journal-title":"Febs J"},{"key":"key\n\t\t\t\t20170405101858_awu002-B104","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1086\/302925","article-title":"Analysis and classification of 304 mutant alleles in patients with type 1 and type 3 Gaucher disease","volume":"66","author":"Koprivica","year":"2000","journal-title":"Am J Hum Genet"},{"key":"key\n\t\t\t\t20170405101858_awu002-B105","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1111\/j.1468-1331.2012.03817.x","article-title":"Glucocerebrosidase mutations in a Serbian Parkinson's disease population","volume":"20","author":"Kumar","year":"2013","journal-title":"Eur J Neurol"},{"issue":"Pt 21","key":"key\n\t\t\t\t20170405101858_awu002-B106","doi-asserted-by":"crossref","first-page":"4117","DOI":"10.1242\/jcs.00075","article-title":"A role for the lysosomal membrane protein LGP85 in the biogenesis and maintenance of endosomal and lysosomal morphology","volume":"115","author":"Kuronita","year":"2002","journal-title":"J Cell Sci"},{"key":"key\n\t\t\t\t20170405101858_awu002-B107","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1093\/qjmed\/hch036","article-title":"Twin pairs showing discordance of phenotype in adult Gaucher's disease","volume":"97","author":"Lachmann","year":"2004","journal-title":"Qjm"},{"key":"key\n\t\t\t\t20170405101858_awu002-B108","first-page":"79","article-title":"Complex alleles of the acid beta-glucosidase gene in Gaucher disease","volume":"47","author":"Latham","year":"1990","journal-title":"Am J Hum Genet"},{"key":"key\n\t\t\t\t20170405101858_awu002-B109","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.devcel.2011.12.014","article-title":"Role of PINK1 binding to the TOM complex and alternate intracellular membranes in recruitment and activation of the E3 ligase Parkin","volume":"22","author":"Lazarou","year":"2012","journal-title":"Dev Cell"},{"key":"key\n\t\t\t\t20170405101858_awu002-B110","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.bbrc.2011.08.080","article-title":"Protective effect of catechin in type I Gaucher disease cells by reducing endoplasmic reticulum stress","volume":"413","author":"Lee","year":"2011","journal-title":"Biochem Biophys Res Commun"},{"key":"key\n\t\t\t\t20170405101858_awu002-B111","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1093\/hmg\/ddq454","article-title":"Large-scale screening of the Gaucher's disease-related glucocerebrosidase gene in Europeans with Parkinson's disease","volume":"20","author":"Lesage","year":"2011","journal-title":"Hum Mol Genet"},{"key":"key\n\t\t\t\t20170405101858_awu002-B112","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1212\/WNL.0b013e318207b01e","article-title":"Mutations in the glucocerebrosidase gene confer a risk for Parkinson disease in North Africa","volume":"76","author":"Lesage","year":"2011","journal-title":"Neurology"},{"key":"key\n\t\t\t\t20170405101858_awu002-B113","doi-asserted-by":"crossref","first-page":"4816","DOI":"10.1021\/bi9002265","article-title":"Effects of pH and Iminosugar Pharmacological Chaperones on Lysosomal Glycosidase Structure and Stability","volume":"48","author":"Lieberman","year":"2009","journal-title":"Biochemistry"},{"key":"key\n\t\t\t\t20170405101858_awu002-B114","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3389\/fneur.2013.00033","article-title":"Molecular events underlying Parkinson's disease - an interwoven tapestry","volume":"4","author":"Lim","year":"2013","journal-title":"Front Neurol"},{"key":"key\n\t\t\t\t20170405101858_awu002-B115","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.ymgme.2011.12.002","article-title":"Is E326K glucocerebrosidase a polymorphic or pathological variant?","volume":"105","author":"Liou","year":"2012","journal-title":"Mol Genet Metab"},{"key":"key\n\t\t\t\t20170405101858_awu002-B116","doi-asserted-by":"crossref","first-page":"21665","DOI":"10.1073\/pnas.1014376107","article-title":"Decreased glucocerebrosidase activity in Gaucher disease parallels quantitative enzyme loss due to abnormal interaction with TCP1 and c-Cbl","volume":"107","author":"Lu","year":"2010","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"key\n\t\t\t\t20170405101858_awu002-B117","doi-asserted-by":"crossref","first-page":"21200","DOI":"10.1073\/pnas.1119181109","article-title":"Histone deacetylase inhibitors prevent the degradation and restore the activity of glucocerebrosidase in Gaucher disease","volume":"108","author":"Lu","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"key":"key\n\t\t\t\t20170405101858_awu002-B118","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.neurobiolaging.2013.08.015","article-title":"Uncoupling protein 2 deficiency aggravates astrocytic endoplasmic reticulum stress and nod-like receptor protein 3 inflammasome activation","volume":"35","author":"Lu","year":"2014","journal-title":"Neurobiol Aging"},{"key":"key\n\t\t\t\t20170405101858_awu002-B119","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.braindev.2012.05.008","article-title":"The chaperone activity and toxicity of ambroxol on Gaucher cells and normal mice","volume":"35","author":"Luan","year":"2013","journal-title":"Brain Dev"},{"key":"key\n\t\t\t\t20170405101858_awu002-B120","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1182\/blood-2010-03-273151","article-title":"A phase 2 study of eliglustat tartrate (Genz-112638), an oral substrate reduction therapy for Gaucher disease type 1","volume":"116","author":"Lukina","year":"2010","journal-title":"Blood"},{"key":"key\n\t\t\t\t20170405101858_awu002-B121","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.ymgme.2003.11.004","article-title":"Glucocerebrosidase mutations in subjects with parkinsonism","volume":"81","author":"Lwin","year":"2004","journal-title":"Mol Genet Metab"},{"key":"key\n\t\t\t\t20170405101858_awu002-B122","doi-asserted-by":"crossref","first-page":"23502","DOI":"10.1074\/jbc.M109.012393","article-title":"Identification and characterization of ambroxol as an enzyme enhancement agent for Gaucher disease","volume":"284","author":"Maegawa","year":"2009","journal-title":"J Biol Chem"},{"key":"key\n\t\t\t\t20170405101858_awu002-B123","article-title":"Functional analysis of 11 novel GBA alleles","author":"Malini","year":"2013","journal-title":"Eur J Hum Genet"},{"key":"key\n\t\t\t\t20170405101858_awu002-B124","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.ymgme.2013.01.012","article-title":"Is Parkinson disease associated with lysosomal integral membrane protein type-2?: challenges in interpreting association data","volume":"108","author":"Maniwang","year":"2013","journal-title":"Mol Genet Metab"},{"key":"key\n\t\t\t\t20170405101858_awu002-B125","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/j.neuro.2009.06.009","article-title":"Alpha-synuclein-glucocerebrosidase interactions in pharmacological Gaucher models: a biological link between Gaucher disease and parkinsonism","volume":"30","author":"Manning-Bog","year":"2009","journal-title":"Neurotoxicology"},{"key":"key\n\t\t\t\t20170405101858_awu002-B126","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.neulet.2009.12.007","article-title":"Association between GBA L444P mutation and sporadic Parkinson's disease from Mainland China","volume":"469","author":"Mao","year":"2010","journal-title":"Neurosci Lett"},{"key":"key\n\t\t\t\t20170405101858_awu002-B127","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1093\/hmg\/dds535","article-title":"ITCH regulates degradation of mutant glucocerebrosidase: implications to Gaucher disease","volume":"22","author":"Maor","year":"2013","journal-title":"Hum Mol Genet"},{"key":"key\n\t\t\t\t20170405101858_awu002-B128","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1186\/1750-1172-8-140","article-title":"Unfolded protein response in Gaucher disease: from human to Drosophila","volume":"8","author":"Maor","year":"2013","journal-title":"Orphanet J Rare Dis"},{"key":"key\n\t\t\t\t20170405101858_awu002-B129","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1083\/jcb.201209135","article-title":"Rag GTPases mediate amino acid-dependent recruitment of TFEB and MITF to lysosomes","volume":"200","author":"Martina","year":"2013","journal-title":"J Cell Biol"},{"key":"key\n\t\t\t\t20170405101858_awu002-B130","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1001\/archneurol.2007.68","article-title":"Glucocerebrosidase gene mutations: a risk factor for Lewy body disorders","volume":"65","author":"Mata","year":"2008","journal-title":"Arch Neurol"},{"key":"key\n\t\t\t\t20170405101858_awu002-B131","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.cell.2011.06.001","article-title":"Gaucher disease glucocerebrosidase and alpha-synuclein form a bidirectional pathogenic loop in synucleinopathies","volume":"146","author":"Mazzulli","year":"2011","journal-title":"Cell"},{"key":"key\n\t\t\t\t20170405101858_awu002-B132","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.ymgme.2013.06.002","article-title":"Glucosylceramidase degradation in fibroblasts carrying bi-allelic Parkin mutations","volume":"109","author":"McNeill","year":"2013","journal-title":"Mol Genet Metab"},{"key":"key\n\t\t\t\t20170405101858_awu002-B133","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.devcel.2011.07.016","article-title":"Transcriptional activation of lysosomal exocytosis promotes cellular clearance","volume":"21","author":"Medina","year":"2011","journal-title":"Dev Cell"},{"key":"key\n\t\t\t\t20170405101858_awu002-B134","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1002\/mds.24886","article-title":"Evidence of an association between the scavenger receptor class B member 2 gene and Parkinson's disease","volume":"27","author":"Michelakakis","year":"2012","journal-title":"Mov Disord"},{"key":"key\n\t\t\t\t20170405101858_awu002-B135","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1615\/CritRevOncog.2013006145","article-title":"Gaucher disease and malignancy: a model for cancer pathogenesis in an inborn error of metabolism","volume":"18","author":"Mistry","year":"2013","journal-title":"Crit Rev Oncog"},{"key":"key\n\t\t\t\t20170405101858_awu002-B136","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1172\/JCI0214530","article-title":"Systemic inflammation in glucocerebrosidase-deficient mice with minimal glucosylceramide storage","volume":"109","author":"Mizukami","year":"2002","journal-title":"J Clin Invest"},{"key":"key\n\t\t\t\t20170405101858_awu002-B137","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1002\/humu.20043","article-title":"Functional analysis of 13 GBA mutant alleles identified in Gaucher disease patients: Pathogenic changes and \u201cmodifier\u201d polymorphisms","volume":"23","author":"Montfort","year":"2004","journal-title":"Hum Mutat"},{"key":"key\n\t\t\t\t20170405101858_awu002-B138","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.ymgme.2011.06.015","article-title":"beta-Glucocerebrosidase gene mutations in two cohorts of Greek patients with sporadic Parkinson's disease","volume":"104","author":"Moraitou","year":"2011","journal-title":"Mol Genet Metab"},{"key":"key\n\t\t\t\t20170405101858_awu002-B139","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.cell.2008.06.037","article-title":"Chemical and biological approaches synergize to ameliorate protein-folding diseases","volume":"134","author":"Mu","year":"2008","journal-title":"Cell"},{"key":"key\n\t\t\t\t20170405101858_awu002-B140","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1001\/jamaneurol.2013.1925","article-title":"A multicenter study of glucocerebrosidase mutations in dementia with Lewy bodies","volume":"70","author":"Nalls","year":"2013","journal-title":"JAMA Neurol"},{"key":"key\n\t\t\t\t20170405101858_awu002-B141","doi-asserted-by":"crossref","first-page":"e1000298","DOI":"10.1371\/journal.pbio.1000298","article-title":"PINK1 is selectively stabilized on impaired mitochondria to activate Parkin","volume":"8","author":"Narendra","year":"2010","journal-title":"PLoS Biol"},{"issue":"Pt 7","key":"key\n\t\t\t\t20170405101858_awu002-B142","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1093\/brain\/awp044","article-title":"Glucocerebrosidase mutations in clinical and pathologically proven Parkinson's disease","volume":"132","author":"Neumann","year":"2009","journal-title":"Brain"},{"key":"key\n\t\t\t\t20170405101858_awu002-B143","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1017\/S0317167100012300","article-title":"Glucocerebrosidase mutations in a French-Canadian Parkinson's disease cohort","volume":"38","author":"Noreau","year":"2011","journal-title":"Can J Neurol Sci"},{"key":"key\n\t\t\t\t20170405101858_awu002-B144","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/j.cmet.2013.04.014","article-title":"Mitochondria and quality control defects in a mouse model of Gaucher disease\u2013links to Parkinson's disease","volume":"17","author":"Osellame","year":"2013","journal-title":"Cell Metab"},{"key":"key\n\t\t\t\t20170405101858_awu002-B145","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1002\/ana.22687","article-title":"Meta-analysis of Parkinson's disease: identification of a novel locus, RIT2","volume":"71","author":"Pankratz","year":"2012","journal-title":"Annals of neurology"},{"key":"key\n\t\t\t\t20170405101858_awu002-B146","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1007\/s00439-008-0582-9","article-title":"Genomewide association study for susceptibility genes contributing to familial Parkinson disease","volume":"124","author":"Pankratz","year":"2009","journal-title":"Hum Genet"},{"key":"key\n\t\t\t\t20170405101858_awu002-B147","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1034\/j.1399-0004.2002.610106.x","article-title":"The E326K mutation and Gaucher disease: mutation or polymorphism?","volume":"61","author":"Park","year":"2002","journal-title":"Clin Genet"},{"key":"key\n\t\t\t\t20170405101858_awu002-B148","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.nbd.2009.03.002","article-title":"Cerebrospinal fluid beta-glucocerebrosidase activity is reduced in Dementia with Lewy Bodies","volume":"34","author":"Parnetti","year":"2009","journal-title":"Neurobiol Dis"},{"key":"key\n\t\t\t\t20170405101858_awu002-B149","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s11926-000-0059-x","article-title":"Bone and joint complications related to Gaucher disease","volume":"2","author":"Pastores","year":"2000","journal-title":"Curr Rheumatol Rep"},{"key":"key\n\t\t\t\t20170405101858_awu002-B150","doi-asserted-by":"crossref","first-page":"5734","DOI":"10.1021\/jm300063b","article-title":"Discovery, structure-activity relationship, and biological evaluation of noninhibitory small molecule chaperones of glucocerebrosidase","volume":"55","author":"Patnaik","year":"2012","journal-title":"J Med Chem"},{"key":"key\n\t\t\t\t20170405101858_awu002-B151","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.parkreldis.2013.01.020","article-title":"Monogenic Parkinson's disease and parkinsonism: clinical phenotypes and frequencies of known mutations","volume":"19","author":"Puschmann","year":"2013","journal-title":"Parkinsonism Relat Disord"},{"key":"key\n\t\t\t\t20170405101858_awu002-B152","doi-asserted-by":"crossref","first-page":"S24","DOI":"10.1016\/S1353-8020(11)70010-4","article-title":"Synucleinopathies from bench to bedside","volume":"18","author":"Puschmann","year":"2012","journal-title":"Parkinsonism Relat Disord"},{"key":"key\n\t\t\t\t20170405101858_awu002-B153","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF01233949","article-title":"Mutational analysis in a patient with a variant form of Gaucher disease caused by SAP-2 deficiency","volume":"19","author":"Rafi","year":"1993","journal-title":"Somat Cell Mol Genet"},{"key":"key\n\t\t\t\t20170405101858_awu002-B154","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.cell.2007.10.018","article-title":"LIMP-2 is a receptor for lysosomal mannose-6-phosphate-independent targeting of beta-glucocerebrosidase","volume":"131","author":"Reczek","year":"2007","journal-title":"Cell"},{"key":"key\n\t\t\t\t20170405101858_awu002-B155","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1093\/hmg\/ddi240","article-title":"ER retention and degradation as the molecular basis underlying Gaucher disease heterogeneity","volume":"14","author":"Ron","year":"2005","journal-title":"Hum Mol Genet"},{"key":"key\n\t\t\t\t20170405101858_awu002-B156","doi-asserted-by":"crossref","first-page":"3771","DOI":"10.1093\/hmg\/ddq292","article-title":"Interaction between parkin and mutant glucocerebrosidase variants: a possible link between Parkinson disease and Gaucher disease","volume":"19","author":"Ron","year":"2010","journal-title":"Hum Mol Genet"},{"key":"key\n\t\t\t\t20170405101858_awu002-B157","first-page":"217","article-title":"Exosomes-associated neurodegeneration and progression of Parkinson's disease","volume":"1","author":"Russo","year":"2012","journal-title":"Am J Neurodegener Dis"},{"key":"key\n\t\t\t\t20170405101858_awu002-B158","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.cell.2010.02.024","article-title":"Ragulator-Rag complex targets mTORC1 to the lysosomal surface and is necessary for its activation by amino acids","volume":"141","author":"Sancak","year":"2010","journal-title":"Cell"},{"key":"key\n\t\t\t\t20170405101858_awu002-B159","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1126\/science.1157535","article-title":"The Rag GTPases bind raptor and mediate amino acid signaling to mTORC1","volume":"320","author":"Sancak","year":"2008","journal-title":"Science"},{"key":"key\n\t\t\t\t20170405101858_awu002-B160","doi-asserted-by":"crossref","first-page":"3460","DOI":"10.1016\/j.bbamcr.2013.06.028","article-title":"ER stress-induced cell death mechanisms","volume":"1833","author":"Sano","year":"2013","journal-title":"Biochim Biophys Acta"},{"key":"key\n\t\t\t\t20170405101858_awu002-B161","doi-asserted-by":"crossref","first-page":"12101","DOI":"10.1073\/pnas.1108197108","article-title":"CNS expression of glucocerebrosidase corrects alpha-synuclein pathology and memory in a mouse model of Gaucher-related synucleinopathy","volume":"108","author":"Sardi","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"key":"key\n\t\t\t\t20170405101858_awu002-B162","doi-asserted-by":"crossref","first-page":"3537","DOI":"10.1073\/pnas.1220464110","article-title":"Augmenting CNS glucocerebrosidase activity as a therapeutic strategy for parkinsonism and other Gaucher-related synucleinopathies","volume":"110","author":"Sardi","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"key":"key\n\t\t\t\t20170405101858_awu002-B163","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1126\/science.1174447","article-title":"A gene network regulating lysosomal biogenesis and function","volume":"325","author":"Sardiello","year":"2009","journal-title":"Science"},{"key":"key\n\t\t\t\t20170405101858_awu002-B164","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1038\/ng.485","article-title":"Genome-wide association study identifies common variants at four loci as genetic risk factors for Parkinson's disease","volume":"41","author":"Satake","year":"2009","journal-title":"Nat Genet"},{"key":"key\n\t\t\t\t20170405101858_awu002-B165","doi-asserted-by":"crossref","first-page":"3214","DOI":"10.1073\/pnas.1300822110","article-title":"Glucocerebrosidase in the pathogenesis and treatment of Parkinson disease","volume":"110","author":"Schapira","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"key":"key\n\t\t\t\t20170405101858_awu002-B166","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/0014-5793(91)80760-Z","article-title":"Mutation in the sphingolipid activator protein 2 in a patient with a variant of Gaucher disease","volume":"284","author":"Schnabel","year":"1991","journal-title":"FEBS Lett"},{"key":"key\n\t\t\t\t20170405101858_awu002-B167","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1038\/35008096","article-title":"Rapid degradation of a large fraction of newly synthesized proteins by proteasomes","volume":"404","author":"Schubert","year":"2000","journal-title":"Nature"},{"key":"key\n\t\t\t\t20170405101858_awu002-B168","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1093\/hmg\/ddt057","article-title":"Atp13a2-deficient mice exhibit neuronal ceroid lipofuscinosis, limited alpha-synuclein accumulation and age-dependent sensorimotor deficits","volume":"22","author":"Schultheis","year":"2013","journal-title":"Hum Mol Genet"},{"key":"key\n\t\t\t\t20170405101858_awu002-B169","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1212\/01.wnl.0000345356.40399.eb","article-title":"Glucocerebrosidase mutations in 108 neuropathologically confirmed cases of multiple system atrophy","volume":"72","author":"Segarane","year":"2009","journal-title":"Neurology"},{"key":"key\n\t\t\t\t20170405101858_awu002-B170","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.4161\/auto.7.11.17166","article-title":"TFEB regulates autophagy: an integrated coordination of cellular degradation and recycling processes","volume":"7","author":"Settembre","year":"2011","journal-title":"Autophagy"},{"key":"key\n\t\t\t\t20170405101858_awu002-B171","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1038\/ncb2718","article-title":"TFEB controls cellular lipid metabolism through a starvation-induced autoregulatory loop","volume":"15","author":"Settembre","year":"2013","journal-title":"Nat Cell Biol"},{"key":"key\n\t\t\t\t20170405101858_awu002-B172","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1038\/emboj.2012.32","article-title":"A lysosome-to-nucleus signalling mechanism senses and regulates the lysosome via mTOR and TFEB","volume":"31","author":"Settembre","year":"2012","journal-title":"EMBO J"},{"key":"key\n\t\t\t\t20170405101858_awu002-B173","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1002\/mds.23774","article-title":"Lysosomal storage disorders and Parkinson's disease: Gaucher disease and beyond","volume":"26","author":"Shachar","year":"2011","journal-title":"Mov Disord"},{"key":"key\n\t\t\t\t20170405101858_awu002-B174","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.ymgme.2004.08.015","article-title":"Gaucher disease: complexity in a \u201csimple\u201d disorder","volume":"83","author":"Sidransky","year":"2004","journal-title":"Mol Genet Metab"},{"key":"key\n\t\t\t\t20170405101858_awu002-B175","first-page":"273","article-title":"Gaucher disease: insights from a rare Mendelian disorder","volume":"14","author":"Sidransky","year":"2012","journal-title":"Discov Med"},{"key":"key\n\t\t\t\t20170405101858_awu002-B176","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/S1474-4422(12)70190-4","article-title":"The link between the GBA gene and parkinsonism","volume":"11","author":"Sidransky","year":"2012","journal-title":"Lancet Neurol"},{"key":"key\n\t\t\t\t20170405101858_awu002-B177","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1056\/NEJMoa0901281","article-title":"Multicenter analysis of glucocerebrosidase mutations in Parkinson's disease","volume":"361","author":"Sidransky","year":"2009","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20170405101858_awu002-B178","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1038\/ng.487","article-title":"Genome-wide association study reveals genetic risk underlying Parkinson's disease","volume":"41","author":"Simon-Sanchez","year":"2009","journal-title":"Nat Genet"},{"key":"key\n\t\t\t\t20170405101858_awu002-B179","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0304-3940(98)00504-7","article-title":"Filamentous alpha-synuclein inclusions link multiple system atrophy with Parkinson's disease and dementia with Lewy bodies","volume":"251","author":"Spillantini","year":"1998","journal-title":"Neurosci Lett"},{"key":"key\n\t\t\t\t20170405101858_awu002-B180","doi-asserted-by":"crossref","first-page":"e61","DOI":"10.1111\/ene.12086","article-title":"No association of GBA mutations and multiple system atrophy","volume":"20","author":"Srulijes","year":"2013","journal-title":"Eur J Neurol"},{"key":"key\n\t\t\t\t20170405101858_awu002-B181","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.jocn.2012.01.055","article-title":"Genetic association study of glucocerebrosidase gene L444P mutation in essential tremor and multiple system atrophy in mainland China","volume":"20","author":"Sun","year":"2013","journal-title":"J Clin Neurosci"},{"key":"key\n\t\t\t\t20170405101858_awu002-B182","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1093\/hmg\/ddp580","article-title":"Neuronopathic Gaucher disease in the mouse: viable combined selective saposin C deficiency and mutant glucocerebrosidase (V394L) mice with glucosylsphingosine and glucosylceramide accumulation and progressive neurological deficits","volume":"19","author":"Sun","year":"2010","journal-title":"Hum Mol Genet"},{"key":"key\n\t\t\t\t20170405101858_awu002-B183","doi-asserted-by":"crossref","first-page":"4275","DOI":"10.1074\/jbc.M111.280016","article-title":"Ex vivo and in vivo effects of isofagomine on acid beta-glucosidase variants and substrate levels in Gaucher disease","volume":"287","author":"Sun","year":"2012","journal-title":"J Biol Chem"},{"key":"key\n\t\t\t\t20170405101858_awu002-B184","doi-asserted-by":"crossref","first-page":"31918","DOI":"10.1074\/jbc.M302752200","article-title":"saposin C is required for normal resistance of acid beta-glucosidase to proteolytic degradation","volume":"278","author":"Sun","year":"2003","journal-title":"J Biol Chem"},{"key":"key\n\t\t\t\t20170405101858_awu002-B185","doi-asserted-by":"crossref","first-page":"e19037","DOI":"10.1371\/journal.pone.0019037","article-title":"Isofagomine in vivo effects in a neuronopathic Gaucher disease mouse","volume":"6","author":"Sun","year":"2011","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20170405101858_awu002-B186","doi-asserted-by":"crossref","first-page":"e57560","DOI":"10.1371\/journal.pone.0057560","article-title":"Substrate compositional variation with tissue\/region and Gba1 mutations in mouse models\u2013implications for Gaucher disease","volume":"8","author":"Sun","year":"2013","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20170405101858_awu002-B187","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.ymgme.2012.04.024","article-title":"The role of saposin C in Gaucher disease","volume":"106","author":"Tamargo","year":"2012","journal-title":"Mol Genet Metab"},{"key":"key\n\t\t\t\t20170405101858_awu002-B188","doi-asserted-by":"crossref","first-page":"241","DOI":"10.4161\/auto.22557","article-title":"Cathepsin-mediated regulation of autophagy in saposin C deficiency","volume":"9","author":"Tatti","year":"2013","journal-title":"Autophagy"},{"key":"key\n\t\t\t\t20170405101858_awu002-B189","doi-asserted-by":"crossref","first-page":"5159","DOI":"10.1093\/hmg\/dds367","article-title":"Reduced cathepsins B and D cause impaired autophagic degradation that can be almost completely restored by overexpression of these two proteases in Sap C-deficient fibroblasts","volume":"21","author":"Tatti","year":"2012","journal-title":"Hum Mol Genet"},{"key":"key\n\t\t\t\t20170405101858_awu002-B190","doi-asserted-by":"crossref","first-page":"94","DOI":"10.4161\/auto.7.1.13884","article-title":"Autophagy in Gaucher disease due to saposin C deficiency","volume":"7","author":"Tatti","year":"2011","journal-title":"Autophagy"},{"issue":"4","key":"key\n\t\t\t\t20170405101858_awu002-B191","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1006\/mgme.2001.3201","article-title":"Gaucher disease and parkinsonism: a phenotypic and genotypic characterization","volume":"73","author":"Tayebi","year":"2001","journal-title":"Mol Genet Metab"},{"issue":"2","key":"key\n\t\t\t\t20170405101858_awu002-B192","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/S1096-7192(03)00071-4","article-title":"Gaucher disease with parkinsonian manifestations: does glucocerebrosidase deficiency contribute to a vulnerability to parkinsonism?","volume":"79","author":"Tayebi","year":"2003","journal-title":"Mol Genet Metab"},{"key":"key\n\t\t\t\t20170405101858_awu002-B193","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1042\/BSR20130081","article-title":"Glycosylation and Functionality of Recombinant ss-Glucocerebrosidase from Various Production Systems","volume":"33","author":"Tekoah","year":"2013","journal-title":"Biosci Rep"},{"key":"key\n\t\t\t\t20170405101858_awu002-B194","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1091\/mbc.E09-09-0801","article-title":"Alpha-synuclein delays endoplasmic reticulum (ER)-to-Golgi transport in mammalian cells by antagonizing ER\/Golgi SNAREs","volume":"21","author":"Thayanidhi","year":"2010","journal-title":"Mol Biol Cell"},{"key":"key\n\t\t\t\t20170405101858_awu002-B195","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1002\/mds.25136","article-title":"Lysosome-dependent pathways as a unifying theme in Parkinson's disease","volume":"27","author":"Tofaris","year":"2012","journal-title":"Mov Disord"},{"key":"key\n\t\t\t\t20170405101858_awu002-B196","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1212\/WNL.0b013e3182735e9a","article-title":"GBA mutations increase risk for Lewy body disease with and without Alzheimer disease pathology","volume":"79","author":"Tsuang","year":"2012","journal-title":"Neurology"},{"key":"key\n\t\t\t\t20170405101858_awu002-B197","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/357407a0","article-title":"Animal model of Gaucher's disease from targeted disruption of the mouse glucocerebrosidase gene","volume":"357","author":"Tybulewicz","year":"1992","journal-title":"Nature"},{"key":"key\n\t\t\t\t20170405101858_awu002-B198","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1111\/j.1399-0004.2007.00899.x","article-title":"Non-neuronopathic Gaucher disease due to saposin C deficiency","volume":"72","author":"Tylki-Szymanska","year":"2007","journal-title":"Clin Genet"},{"key":"key\n\t\t\t\t20170405101858_awu002-B199","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.ymgme.2011.09.010","article-title":"Gaucher disease due to saposin C deficiency, previously described as non-neuronopathic form\u2013no positive effects after 2-years of miglustat therapy","volume":"104","author":"Tylki-Szymanska","year":"2011","journal-title":"Mol Genet Metab"},{"key":"key\n\t\t\t\t20170405101858_awu002-B200","doi-asserted-by":"crossref","first-page":"2987","DOI":"10.1093\/hmg\/ddq204","article-title":"saposin C mutations in Gaucher disease patients resulting in lysosomal lipid accumulation, saposin C deficiency, but normal prosaposin processing and sorting","volume":"19","author":"Vaccaro","year":"2010","journal-title":"Hum Mol Genet"},{"key":"key\n\t\t\t\t20170405101858_awu002-B201","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1016\/B978-0-444-59565-2.00041-1","article-title":"Niemann-Pick diseases","volume":"113","author":"Vanier","year":"2013","journal-title":"Handb Clin Neurol"},{"key":"key\n\t\t\t\t20170405101858_awu002-B202","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1002\/humu.21566","article-title":"A mutation in SCARB2 is a modifier in Gaucher disease","volume":"32","author":"Velayati","year":"2011","journal-title":"Hum Mutat"},{"key":"key\n\t\t\t\t20170405101858_awu002-B203","doi-asserted-by":"crossref","first-page":"17897","DOI":"10.3390\/ijms140917897","article-title":"Oxidative stress in aging-matters of the heart and mind","volume":"14","author":"Venkataraman","year":"2013","journal-title":"Int J Mol Sci"},{"key":"key\n\t\t\t\t20170405101858_awu002-B204","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1083\/jcb.201110131","article-title":"The impact of the unfolded protein response on human disease","volume":"197","author":"Wang","year":"2012","journal-title":"J Cell Biol"},{"key":"key\n\t\t\t\t20170405101858_awu002-B205","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/1744-9081-8-57","article-title":"Glucocerebrosidase L444P mutation confers genetic risk for Parkinson's disease in central China","volume":"8","author":"Wang","year":"2012","journal-title":"Behav Brain Funct"},{"key":"key\n\t\t\t\t20170405101858_awu002-B206","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1093\/hmg\/ddm324","article-title":"ER and oxidative stresses are common mediators of apoptosis in both neurodegenerative and non-neurodegenerative lysosomal storage disorders and are alleviated by chemical chaperones","volume":"17","author":"Wei","year":"2008","journal-title":"Hum Mol Genet"},{"key":"key\n\t\t\t\t20170405101858_awu002-B207","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1615\/CritRevOncog.2013005921","article-title":"Causes of death due to hematological and non-hematological cancers in 57 US patients with type 1 Gaucher Disease who were never treated with enzyme replacement therapy","volume":"18","author":"Weinreb","year":"2013","journal-title":"Crit Rev Oncog"},{"key":"key\n\t\t\t\t20170405101858_awu002-B208","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.molmed.2011.05.003","article-title":"Exploring the link between glucocerebrosidase mutations and parkinsonism","volume":"17","author":"Westbroek","year":"2011","journal-title":"Trends Mol Med"},{"key":"key\n\t\t\t\t20170405101858_awu002-B209","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1002\/mds.24029","article-title":"Genetic and pathological links between Parkinson's disease and the lysosomal disorder Sanfilippo syndrome","volume":"27","author":"Winder-Rhodes","year":"2012","journal-title":"Mov Disord"},{"key":"key\n\t\t\t\t20170405101858_awu002-B210","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1101\/gr.7.10.1020","article-title":"Identification of three additional genes contiguous to the glucocerebrosidase locus on chromosome 1q21: implications for Gaucher disease","volume":"7","author":"Winfield","year":"1997","journal-title":"Genome Res"},{"key":"key\n\t\t\t\t20170405101858_awu002-B211","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1083\/jcb.201003122","article-title":"alpha-Synuclein impairs macroautophagy: implications for Parkinson's disease","volume":"190","author":"Winslow","year":"2010","journal-title":"J Cell Biol"},{"key":"key\n\t\t\t\t20170405101858_awu002-B212","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.neulet.2011.05.238","article-title":"Genetic analysis of lysosomal alpha-galactosidase A gene in sporadic Parkinson's disease","volume":"500","author":"Wu","year":"2011","journal-title":"Neurosci Lett"},{"key":"key\n\t\t\t\t20170405101858_awu002-B213","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.jns.2008.04.011","article-title":"Decreased activities of lysosomal acid alpha-D-galactosidase A in the leukocytes of sporadic Parkinson's disease","volume":"271","author":"Wu","year":"2008","journal-title":"J Neurol Sci"},{"key":"key\n\t\t\t\t20170405101858_awu002-B214","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1016\/S0002-9440(10)63566-3","article-title":"Viable mouse models of acid beta-glucosidase deficiency: the defect in Gaucher disease","volume":"163","author":"Xu","year":"2003","journal-title":"Am J Pathol"},{"key":"key\n\t\t\t\t20170405101858_awu002-B215","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1073\/pnas.1221046110","article-title":"Histone deacetylase inhibitors increase glucocerebrosidase activity in Gaucher disease by modulation of molecular chaperones","volume":"110","author":"Yang","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"key":"key\n\t\t\t\t20170405101858_awu002-B216","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1038\/ncb0910-814","article-title":"Eaten alive: a history of macroautophagy","volume":"12","author":"Yang","year":"2010","journal-title":"Nat Cell Biol"},{"key":"key\n\t\t\t\t20170405101858_awu002-B217","doi-asserted-by":"crossref","first-page":"28080","DOI":"10.1074\/jbc.M111.237859","article-title":"Alpha-synuclein interacts with Glucocerebrosidase providing a molecular link between Parkinson and Gaucher diseases","volume":"286","author":"Yap","year":"2011","journal-title":"J Biol Chem"},{"key":"key\n\t\t\t\t20170405101858_awu002-B218","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ymgme.2012.11.010","article-title":"Membrane-bound alpha-synuclein interacts with glucocerebrosidase and inhibits enzyme activity","volume":"108","author":"Yap","year":"2013","journal-title":"Mol Genet Metab"},{"key":"key\n\t\t\t\t20170405101858_awu002-B219","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1016\/j.yexcr.2011.07.017","article-title":"Prosaposin sorting is mediated by oligomerization","volume":"317","author":"Yuan","year":"2011","journal-title":"Exp Cell Res"},{"key":"key\n\t\t\t\t20170405101858_awu002-B220","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1111\/j.1600-0854.2012.01372.x","article-title":"A critical histidine residue within LIMP-2 mediates pH sensitive binding to its ligand beta-glucocerebrosidase","volume":"13","author":"Zachos","year":"2012","journal-title":"Traffic"},{"key":"key\n\t\t\t\t20170405101858_awu002-B221","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.ymgme.2007.03.004","article-title":"Glucocerebrosidase mutations in Chinese subjects from Taiwan with sporadic Parkinson disease","volume":"91","author":"Ziegler","year":"2007","journal-title":"Mol Genet Metab"},{"key":"key\n\t\t\t\t20170405101858_awu002-B6","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1182\/blood-2011-04-308890","article-title":"How I treat Gaucher disease","volume":"118","author":"Zimran","year":"2011","journal-title":"Blood"},{"key":"key\n\t\t\t\t20170405101858_awu002-B222","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.bcmd.2012.09.006","article-title":"Pilot study using ambroxol as a pharmacological chaperone in type 1 Gaucher disease","volume":"50","author":"Zimran","year":"2013","journal-title":"Blood Cells Mol Dis"},{"key":"key\n\t\t\t\t20170405101858_awu002-B223","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.bcmd.2005.03.004","article-title":"Incidence of malignancies among patients with type I Gaucher disease from a single referral clinic","volume":"34","author":"Zimran","year":"2005","journal-title":"Blood Cells Mol Dis"},{"key":"key\n\t\t\t\t20170405101858_awu002-B224","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1126\/science.1207056","article-title":"mTORC1 senses lysosomal amino acids through an inside-out mechanism that requires the vacuolar H(+)-ATPase","volume":"334","author":"Zoncu","year":"2011","journal-title":"Science"}],"container-title":["Brain"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/brain\/article-pdf\/137\/5\/1304\/11138201\/awu002.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,7]],"date-time":"2019-08-07T17:28:12Z","timestamp":1565198892000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/brain\/article-lookup\/doi\/10.1093\/brain\/awu002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2,14]]},"references-count":223,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2014,2,14]]},"published-print":{"date-parts":[[2014,5]]}},"URL":"https:\/\/doi.org\/10.1093\/brain\/awu002","relation":{},"ISSN":["1460-2156","0006-8950"],"issn-type":[{"value":"1460-2156","type":"electronic"},{"value":"0006-8950","type":"print"}],"subject":[],"published":{"date-parts":[[2014,2,14]]}}}